Pharmascroll Research and Consulting Pvt Ltd

Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to help them make better informed business decisions with the detailed relevant information available.

The Pharmascroll team consists of numerous dedicated and knowledgeable research analysts with a strong background in pharmaceuticals, statistical and management space. The Pharmascroll research reports are an outcome of the combined research of these analysts at Pharmascroll. The reports are constructed relying on the meticulous secondary research and series of primary researches which Pharmascroll conducts in the markets on regular basis. The secondary research sources included in Pharmascroll reports include company websites, financial reports, journals, investor relations presentations, multiple online research articles, papers and news items and many other secondary databases which Pharmascroll has a subscription for.


Research Reports By Pharmascroll Research and Consulting Pvt Ltd

Found 66 publications
Schizophrenia: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Alzheimer’s: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
COPD: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Depression: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Parkinson's: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
COPD: Disease Inights and Market Forecasts to 2024 US$ 5,000.00 Apr, 2018 120 pages
Asthma: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
COPD: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Depression: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Asthma: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Epilepsy: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Schizophrenia: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
ADHD: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
COPD: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Cystic Fibrosis: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Parkinson's: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Asthma: Disease Inights and Market Forecasts to 2024 US$ 5,000.00 Apr, 2018 120 pages
Asthma: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Epilepsy: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Rhinitis: Market Intelligence Review and Insights US$ 2,500.00 Apr, 2018 50 pages
Alzheimer's: Pipeline Assessment and Insights US$ 2,000.00 Apr, 2018 100 pages
Epilepsy: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Rhinitis: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Cystic Fibrosis: Epidemiology Overview and Insights US$ 2,000.00 Apr, 2018 50 pages
Migraine- Detailed overview Acute Treatments US$ 4,000.00 Jan, 2018 87 pages
Migraine- A Detailed overview US$ 5,000.00 Jan, 2018 125 pages
Migraine- Disease overview and Epidemiology US$ 2,000.00 Jan, 2018 30 pages
Migraine- Disease overview US$ 1,000.00 Jan, 2018 21 pages
Migraine- Detailed overview Prophylactic Treatments US$ 4,000.00 Jan, 2018 90 pages
SPMS- Disease Overview US$ 1,000.00 Oct, 2017 18 pages
PPMS- France Overview US$ 3,000.00 Oct, 2017 73 pages
SPMS- Spain Overview US$ 3,000.00 Oct, 2017 78 pages
PPMS- Disease Overview US$ 1,000.00 Oct, 2017 20 pages
1 2
Skip to top

Analytics & News by Pharmascroll Research and Consulting Pvt Ltd